- Home
- MRVI vs UAMY Comparison
MRVI vs UAMY Comparison
Compare MRVI & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- UAMY
- Stock Information
- Founded
- MRVI 2014
- UAMY 1968
- Country
- MRVI United States
- UAMY United States
- Employees
- MRVI N/A
- UAMY N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- UAMY Metal Fabrications
- Sector
- MRVI Health Care
- UAMY Industrials
- Exchange
- MRVI Nasdaq
- UAMY Nasdaq
- Market Cap
- MRVI 312.4M
- UAMY 251.9M
- IPO Year
- MRVI 2020
- UAMY N/A
- Fundamental
- Price
- MRVI $2.67
- UAMY $3.00
- Analyst Decision
- MRVI Hold
- UAMY Strong Buy
- Analyst Count
- MRVI 10
- UAMY 4
- Target Price
- MRVI $6.84
- UAMY $3.38
- AVG Volume (30 Days)
- MRVI 1.9M
- UAMY 5.0M
- Earning Date
- MRVI 08-06-2025
- UAMY 08-08-2025
- Dividend Yield
- MRVI N/A
- UAMY N/A
- EPS Growth
- MRVI N/A
- UAMY N/A
- EPS
- MRVI N/A
- UAMY N/A
- Revenue
- MRVI $241,856,000.00
- UAMY $18,865,900.00
- Revenue This Year
- MRVI N/A
- UAMY $270.45
- Revenue Next Year
- MRVI $10.62
- UAMY $104.06
- P/E Ratio
- MRVI N/A
- UAMY N/A
- Revenue Growth
- MRVI N/A
- UAMY 97.46
- 52 Week Low
- MRVI $1.67
- UAMY $0.27
- 52 Week High
- MRVI $10.03
- UAMY $3.86
- Technical
- Relative Strength Index (RSI)
- MRVI 59.30
- UAMY 63.46
- Support Level
- MRVI $2.52
- UAMY $2.71
- Resistance Level
- MRVI $2.93
- UAMY $2.33
- Average True Range (ATR)
- MRVI 0.18
- UAMY 0.24
- MACD
- MRVI 0.03
- UAMY 0.07
- Stochastic Oscillator
- MRVI 69.41
- UAMY 94.32
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.